You Position: Home > Paper

Effect of Oxymatrine on chronic hepatitis B: an analysis of 312 cases

( views:191, downloads:8 )
Author:
No author available
Journal Title:
WORLD CHINESE JOURNAL OF DIGESTOLOGY
Issue:
3
DOI:
10.3969/j.issn.1009-3079.2005.03.011
Key Word:
苦参素;拉米夫定;慢性乙型肝炎;应答

Abstract: 目的:探讨苦参素治疗慢性乙型肝炎的疗效、安全性及影响应答反应的相关因素.方法:采取回顾性分析方法,对203例单独接受苦参素治疗与109例接受苦参素联合拉米夫定治疗的慢性乙型肝炎患者的临床资料进行回顾性分析,观察应答反应情况及影响应答反应的相关因素.结果:312例患者完全应答率(CR)为36.5%,持续应答(SR)率32.4%;恶化率8.0%;基线ALT<1334nkat/L、1 334 nkat/L≤ALT<3 335 nkat/L、3 335 nkat/L≤ALT<6 670nkat/L及ALT≥6 670nkat/L的患者CR和SR分别为21.4%,33.8%,39.7%及59.5%和14.3%,31.6%,38.5%及47.6%(P=0.0 012和0.0 027);HBVDNA<108copies/L、108copies/L≤HBVDNA≤1011copies/L及HBVDNA>1011 copies/L的患者完全应答和持续应答率分别为57.9%,37.4%及26.5%和50.0%,28.9%及8.2%(P=0.0 262和0.0 070);苦参素治疗乙肝疗程以6 mo时应答反应率最高,延长疗程应答率进一步提高有限;联合拉米夫定治疗的患者完全应答和持续应答率分别为46.8%和41.3%高于单用苦参素的31.0%和27.6%(P=0.0 048和0.0 020),而恶化病例发生率明显低于单用苦参素组(11.3% vs 1.8%,P=0.0 009).结论:苦参素治疗慢性乙型肝炎有肯定的疗效,应答反应随基线ALT水平的升高而升高,而与治疗前HBVDNA水平呈负相关;苦参素单用治疗乙肝部分病例可发生病情恶化,联合拉米夫定治疗可提高应答反应率并降低恶化病例的发生率.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn